Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

NCT00118638 ·Status: COMPLETED ·Phase: PHASE3

Darbepoetin Alfa and Anemia of Cancer

NCT00989092 ·Status: TERMINATED ·Phase: PHASE2

Darbepoetin Alfa With or Without Intravenous (IV) Iron

NCT00401544 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy Related Anemia

NCT00035607 ·Status: COMPLETED ·Phase: PHASE2

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

NCT00858364 ·Status: TERMINATED ·Phase: PHASE3

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00111137 ·Status: COMPLETED ·Phase: PHASE3

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

NCT00070382 ·Status: COMPLETED ·Phase: PHASE3

Anemia in Patients With a Non-Myeloid Malignancy

NCT00038064 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00120705 ·Status: COMPLETED ·Phase: PHASE2

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

NCT00239239 ·Status: COMPLETED ·Phase: PHASE2

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

NCT00148421 ·Status: COMPLETED ·Phase: PHASE3

A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy

NCT03776032 ·Status: COMPLETED ·Phase: PHASE3

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

NCT00661999 ·Status: COMPLETED ·Phase: PHASE3

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

NCT00416624 ·Status: COMPLETED ·Phase: PHASE2

AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies

NCT00135317 ·Status: COMPLETED ·Phase: PHASE3

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

NCT00036023 ·Status: COMPLETED ·Phase: PHASE2

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

NCT00120679 ·Status: COMPLETED ·Phase: PHASE2

Treatment for Patients Suffering From Anemia Due to Chemotherapy

NCT00120692 ·Status: COMPLETED ·Phase: PHASE2

A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer

NCT00153868 ·Status: COMPLETED ·Phase: PHASE4

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

NCT00270127 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients

NCT00344409 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

NCT00270166 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

NCT00083486 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

NCT00210002 ·Status: TERMINATED ·Phase: PHASE2

Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa

NCT00540696 ·Status: COMPLETED ·Phase: PHASE2